Colon Cancer
Adjuvant interleukin-12 immunogene therapy manages metastatic lesions
Published in Gene Therapy Weekly, February 17th, 2005
"In humans, no efficient treatment exists not only against multifocal liver metastases (LM) but also against recurrent microscopic liver metastases within the liver remnant following curative liver resection. Furthermore, in non-multifocal LM, partial liver resection could be performed, but in more than 50% of the patients, tumor recurrence within liver remnant is observed, partly due to the growth of dormant cancer cells in the setting of postoperative host immune dysfunction," investigators in France report.
"We investigated the therapeutic potential of interleukin-12 (IL-12)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-02-17)
More Articles from Gene Therapy Weekly
- Enzymology
Suicide gene therapy converts ethanol to a cancer cell toxin - Oncology
Antibody-mediated p53 transduction destroys cancer cells - Oncology
Antisense blockade of glucose transporter 5 cuts off breast cancer cell growth - Oncology
Reports add new data to oncology research - Vector Development
Replication-competent adenoviruses are safe gene and vaccine vectors - Allergy & Immunology
Down-regulated STAT6 curtails acute and chronic contact hypersensitivity - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
